Influenza, Human  >>  Relenza (zanamivir)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Relenza (zanamivir) / GSK, Vaxart
Combina, NCT00830323 / 2008-004543-11: Efficacy and Safety of tion Therapies With Oseltamivir & Zanamivir or Oseltamivir & Amantadine Versus Oseltamivir Monotherapy in the Treatment of Seasonal Influenza A Infection

Terminated
2
60
Europe
oseltamivir + zanamivir, oseltamivir+ amantadine, oseltamivir
Hospices Civils de Lyon
Influenza A Infection
08/09
08/09
NCT00867139: TCAD vs. Monotherapy for Influenza A in Immunocompromised Patients

Completed
1/2
7
US
TCAD, Symmetrel, Rebetol, Tamiflu, Zanamivir or Oseltamivir, Relenza, Open label treatment with TCAD
Fred Hutchinson Cancer Center
Influenza
08/09
01/10

Download Options